COVID-19患者胸部超声与标准X线成像的比较
Comparison of Chest Ultrasound and Standard X-Ray Imaging in COVID-19 Patients.
作者信息
Shumilov Evgenii, Hosseini Ali Seif Amir, Petzold Golo, Treiber Hannes, Lotz Joachim, Ellenrieder Volker, Kunsch Steffen, Neesse Albrecht
机构信息
Department of Hematology and Medical Oncology, University Medical Center Göttingen, Gottingen, Germany.
Department of Diagnostic and Interventional Radiology, University Medical Center Göttingen, Gottingen, Germany.
出版信息
Ultrasound Int Open. 2020 Sep;6(2):E36-E40. doi: 10.1055/a-1217-1603. Epub 2020 Sep 2.
PURPOSE
The COVID-19 pandemic poses new challenges for the medical community due to its large number of patients presenting with varying symptoms. Chest ultrasound (ChUS) may be particularly useful in the early clinical management in suspected COVID-19 patients due to its broad availability and rapid application. We aimed to investigate patterns of ChUS in COVID-19 patients and compare the findings with results from chest X-ray (CRX).
MATERIALS AND METHODS
24 patients (18 symptomatic, 6 asymptomatic) with confirmed SARS-CoV-2 by polymerase chain reaction underwent bedside ChUS in addition to CRX following admission. Subsequently, the results of ChUS and CRX were compared.
RESULTS
94% (n=17/18) of patients with respiratory symptoms demonstrated lung abnormalities on ChUS. ChUS was especially useful to detect interstitial syndrome compared to CXR in COVID-19 patients (17/18 vs. 11/18; p<0.02). Of note, ChUS also detected lung consolidations very effectively (14/18 for ChUS vs. 7/18 cases for CXR; p<0.02). Besides pathological B-lines and subpleural consolidations, pleural line abnormality (89%; n=16/18) was the third most common feature in patients with respiratory manifestations of COVID-19 detected by ChUS.
CONCLUSION
Our findings support the high value of ChUS in the management of COVID-19 patients.
目的
由于大量感染新型冠状病毒肺炎（COVID-19）的患者表现出不同症状，该疫情给医学界带来了新的挑战。胸部超声（ChUS）因其广泛可用性和快速应用，在疑似COVID-19患者的早期临床管理中可能特别有用。我们旨在研究COVID-19患者的ChUS模式，并将结果与胸部X线（CRX）结果进行比较。
材料与方法
24例经聚合酶链反应确诊为严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的患者（18例有症状，6例无症状）入院后除接受CRX检查外，还接受了床边ChUS检查。随后，比较ChUS和CRX的结果。
结果
94%（n = 17/18）有呼吸道症状的患者在ChUS检查中显示肺部异常。与CRX相比，ChUS在检测COVID-19患者的间质性综合征方面特别有用（17/18 vs. 11/18；p<0.02）。值得注意的是，ChUS在检测肺实变方面也非常有效（ChUS为14/18，而CXR为7/18例；p<0.02）。除了病理性B线和胸膜下实变外，胸膜线异常（89%；n = 16/18）是ChUS检测到的COVID-19呼吸道表现患者中第三常见的特征。
结论
我们的研究结果支持ChUS在COVID-19患者管理中的高价值。
Zotero 插件